Mycobacteriophage TM4 Tape-Measure Protein Blocks Entry into Stationary Phase of Tuberculosis
ISEF · 2014 Microbiology Third Award
Overview
The treatment of tuberculosis requires a minimum of 6 months of multidrug therapy. Antibiotic efficacy is complicated by a bacterial subpopulation of “persisters”. The persisters are genotypically susceptible, but phenotypically resistant to antibiotics. Currently, persistence is thought to be a result of dormancy by the bacteria. A possible method to eliminate these persister cells lies in utilizing the tape measure protein (TMP) from phages. These TMPs have homology to resuscitation promoting factor (Rpf) proteins found in Micrococcus luteus, Mycobacterium tuberculosis, and other bacteria. Rpfs are used to resuscitate bacteria from a stationary phase to an active growth. Analysis of data shows that the expression of these proteins blocks the bacteria’s ability to enter stationary phase and thus could prove to be a useful tool in blocking the formation of persistent bacteria and dramatically reducing the length of treatment and formation of antibiotic resistant progeny.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2014
Resources
Related projects
ISEF · 2017
Tacedinaline-Induced Expression of LL37: A Novel Approach to Treating Tuberculosis Infection
ISEF · 2023
Knockdown of the Essential 23S rRNA Methyltransferase, rv3579c, Increases the Susceptibility of Mycobacterium Tuberculosis to Macrolides
ISEF · 2014
The Inception of Infection II: The Antimicrobial and Synergistic Efficiency of Antibiotic Ethambutol and Isoniazid and Bacteriophage D29 in Treating a Model Organism for Tuberculosis
ISEF · 2024
Isolation of Novel Mycobacteriophages From Soil
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair